ARTICLE SUMMARY:
In this week’s picks: FDA clears its first prescription video game therapeutic, and revokes its first COVID-19 test EUA; the EU designates a new IVDR notified body; Medicare updates, and more.
Prescription digital therapeutics are having a moment amid society’s extended focus on social distancing, and the prospects of that moment enduring went up this week with the authorization by FDA of the first prescription video game therapeutic device. That leads this week’s Pathways’ Picks spotlighting key medtech regulatory and reimbursement updates from around the world.
